Your browser doesn't support javascript.
loading
UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications.
Gao, Yingxue; Liu, Yijun; Liu, Youhong; Peng, Yuchong; Yuan, Bowen; Fu, Yuxin; Qi, Xuli; Zhu, Qianling; Cao, Tuoyu; Zhang, Songwei; Yin, Linglong; Li, Xiong.
Afiliación
  • Gao Y; Department of Oncology, Center for Molecular Medicine, Xiangya Hospital, Central South University, China; Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, China.
  • Liu Y; School of Basic Medicine, Changsha Medical University, China.
  • Liu Y; Department of Oncology, Center for Molecular Medicine, Xiangya Hospital, Central South University, China; Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, China.
  • Peng Y; Center for Clinical Precision Pharmacy, The First Affiliated Hospital, Guangdong Pharmaceutical University, China.
  • Yuan B; Department of Pathology, The Third Xiangya Hospital, Central South University, China.
  • Fu Y; Department of Oncology, Center for Molecular Medicine, Xiangya Hospital, Central South University, China; Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, China.
  • Qi X; Department of Oncology, Center for Molecular Medicine, Xiangya Hospital, Central South University, China; Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, China.
  • Zhu Q; Department of Oncology, Center for Molecular Medicine, Xiangya Hospital, Central South University, China; Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, China.
  • Cao T; Department of Oncology, Center for Molecular Medicine, Xiangya Hospital, Central South University, China; Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, China.
  • Zhang S; Department of Oncology, Center for Molecular Medicine, Xiangya Hospital, Central South University, China; Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, China.
  • Yin L; School of Clinical Pharmacy, Guangdong Pharmaceutical University, China.
  • Li X; Center for Clinical Precision Pharmacy, The First Affiliated Hospital, Guangdong Pharmaceutical University, China; School of Clinical Pharmacy, Guangdong Pharmaceutical University, China; NMPA Key Laboratory for Technology Research and Evaluation of Pharmacovigilance, Guangdong Pharmaceutical Univer
Cancer Lett ; 520: 172-183, 2021 11 01.
Article en En | MEDLINE | ID: mdl-34265399
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Neoplasias de la Próstata / Proteínas Nucleares / Receptores Androgénicos / Proteínas de Ciclo Celular / Proteínas Potenciadoras de Unión a CCAAT / Ubiquitina-Proteína Ligasas / Histona Demetilasas con Dominio de Jumonji Límite: Animals / Humans / Male / Middle aged Idioma: En Revista: Cancer Lett Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Neoplasias de la Próstata / Proteínas Nucleares / Receptores Androgénicos / Proteínas de Ciclo Celular / Proteínas Potenciadoras de Unión a CCAAT / Ubiquitina-Proteína Ligasas / Histona Demetilasas con Dominio de Jumonji Límite: Animals / Humans / Male / Middle aged Idioma: En Revista: Cancer Lett Año: 2021 Tipo del documento: Article País de afiliación: China